Detalhe da pesquisa
1.
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival.
Thromb Res
; 121(6): 763-8, 2008.
Artigo
Inglês
| MEDLINE | ID: mdl-17915296
2.
Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
Thromb Haemost
; 95(4): 606-11, 2006 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16601829
3.
Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
Thromb Haemost
; 88(2): 282-7, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12195701
4.
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.
Blood
; 103(6): 2157-61, 2004 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-14630828
5.
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Hepatology
; 38(1): 230-7, 2003 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-12830006